Best Life Sciences Tech Companies in Canada
The 183 best Life Sciences Tech companies in Canada in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Deep Genomics.
Canada's Life Sciences Tech sector doesn't have a unicorn yet, but $769M in disclosed funding across 183 tracked companies says the infrastructure is building fast. Nomic leads the pack at $63M raised, with ACTO not far behind at $40M, and Intrepid Labs adding another $11M to a funding picture that's broader than most outsiders expect. So what's actually driving the activity? Demand for regulatory compliance tooling and intellectual property protection is pulling capital in, and median app install growth of roughly +43% year-over-year across healthcare and life sciences platforms tells you adoption isn't theoretical. It's happening in users' hands right now.
The investor roster confirms the thesis. Backers like MaRS Discovery District, Ontario Centre of Innovation, and Real Ventures are cycling capital through this ecosystem with real consistency, which I'd argue matters more than any single funding round. You're looking at a sector where institutional support is sticky, not speculative. The directory here ranks the best Life Sciences Tech companies in Canada by disclosed equity funding and recent funding momentum, so if you're mapping the competitive field or sourcing a partner, the list below is the most current snapshot available.
- EVERSANA
- LifeSciencesIntelligence
Our analysis of 50 Life Sciences Tech companies
$9.6b in tracked funding; 89% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences Tech companies in Canada
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Deep Genomics AI-powered platform for RNA biology to accelerate genetic therapy discovery 55AI top 22%Moat top 28%Funding top 29%Patents top 33% All 11 signals ▾AItop 22% Moattop 28% Fundingtop 29% Patentstop 33% Innovationtop 39% Talenttop 41% Marketbottom 49% Globalbottom 43% Techbottom 37% Growthbottom 35% Newsbottom 27% AI: Classified as an AI company · Holds AI/ML patents (G06N-family CPC) Moat: Editorial + unicorn rating 8/10 · IP moat: 92 patents rank vs industry peers · Fliar Intelligence Index 55/100 | $238M | 58 mo ago | Series C | 105 | Brendan Frey Co-Founder & Chief Innovation Officer | WagtailPythonDjango+9 | 92 patents AI-driven genomic variant analysis and therapeutic design for precision medicine | 6 job openings · 1 expansion |
| 2 | Benchsci Developer of an AI platform for understanding disease biology 78AI top 20%Funding top 25%Talent top 28%Moat top 31% All 11 signals ▾AItop 20% Fundingtop 25% Talenttop 28% Moattop 31% Techtop 32% Innovationtop 35% Producttop 37% Markettop 45% Growthtop 45% Globalbottom 37% Newsbottom 32% AI: Classified as an AI company Funding: Raised $170M across 7 rounds · 7 rounds over 10 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 78/100 | $170M | 36 mo ago | Series D | 426 | Elvis Wianda Co-Founder | HubSpot CMS HubSalesforceFacebook Login+20 | — | 1 launch |
| 3 | Nomic Provider of next-generation proteomics platform for drug discovery and protein analysis 60Funding top 27%Growth top 28%Talent top 28%Moat top 39% All 8 signals ▾Fundingtop 27% Growthtop 28% Talenttop 28% Moattop 39% Techtop 46% Globalbottom 43% Marketbottom 39% Newsbottom 18% Funding: Raised $63.0M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 60/100 | $63M | 21 mo ago | Series B | 43 | Jeff Munzar Co-Founder & CTO | WebflowSentryWistia+22 | — | 1 partnership |
| 4 | Gandeeva Provider of precision medicine company leveraging cryo-EM and machine learning for drug discovery | $40M | 52 mo ago | Series A | 35 | Sriram Subramaniam Founder & CEO | WordPressMySQLMariaDB+23 | — | — |
| 5 | ACTO Provider of an AI and SaaS-based educational platform for the life science industry 40Funding top 29%Growth top 37%Moat top 39%Product top 40% All 7 signals ▾Fundingtop 29% Growthtop 37% Moattop 39% Producttop 40% Techtop 48% Globalbottom 43% Marketbottom 29% Funding: Raised $39.5M across 3 rounds · 3 rounds over 6 yrs (0.5/yr) Growth: 1 acquisition/expansion move in 24 mo · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 40/100 | $40M | 21 mo ago | Series B | 18 | — | WordPressMySQLPHP+28 | — | — |
| 6 | Ability Developer of modulating biotherapeutics to address cancer and autoimmune diseases | $30M | 24 mo ago | Seed | — | Jean Buerckert Co-Founder & CTO | WordPressMySQLPHP+9 | — | 1 internship |
| 7 | Genologics Digital LIMS tool for providers | $22M | 152 mo ago | Acqui-Hired | 9 | — | — | — | — |
| 8 | Cyclica AI platform for supporting drug discovery research | $21M | 43 mo ago | Acquired | 56 | Jason Mitakidis Founder | — | 32 patents AI-powered computational drug discovery and proteome-wide ligand docking platforms. | — |
| 9 | DistillerSR AI enabled literature review automation software for life sciences researchers | $21M | 46 mo ago | Series A | 90 | Peter Blenis Co-Founder & CEO | WordPressApple iCloud MailGoogle Workspace+29 | 2 patents Automated document data extraction and configurable form-based information capture. | — |
| 10 | Reliant AI Provider of an AI platform for biopharmaceutical research and development | $11M | 21 mo ago | Acquired | — | Karl Hermann Co-Founder & CEO | WebflowVercelMicrosoft Advertising+13 | — | 1 partnership |
| 11 | Intrepid Labs Developer of drug formulation science to accelerate the development of therapeutics 35Market bottom 49%Funding bottom 49%Talent bottom 49%Global bottom 45% All 4 signals ▾Marketbottom 49% Fundingbottom 49% Talentbottom 49% Globalbottom 45% Funding: Raised $11.0M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 35/100 | $11M | 13 mo ago | Seed | — | Christine Allen Co-Founder and CEO | — | — | — |
| 12 | Pathcore A secure, browser-based platform for managing your digital pathology and radiology images | $10M | 122 mo ago | Funding Raised | 17 | — | WebflowZohojQuery+7 | 6 patents Monitoring tissue exposure to treatment media in medical diagnostic/therapeutic devices | 1 job opening |
| 13 | DrugBank Drug database for life sciences and healthcare and clinical APIs | $9M | 50 mo ago | Seed | 81 | Craig Knox Co-Founder & CTO | Apple iCloud MailGoogle WorkspaceRuby+29 | — | — |
| 14 | Valence Labs AI research engine focusing on advancing drug discovery through computational biology | $8M | 54 mo ago | Acquired | 27 | Therence Bois Co-Founder & COO | WordPressMySQLPHP+20 | — | 1 launch |
| 15 | Find Therapeutics Developer of targeted therapies modulating membrane receptors for autoimmune diseases | $8M | 21 mo ago | Series A | 8 | Philippe Douville Chief Executive Officer | — | — | — |
| 16 | Phenomic AI Developer of deep learning based tools for drug discovery | $8M | 68 mo ago | Seed | 32 | Sam Cooper Co-Founder & CEO | BootstrapApache HTTP ServerAmazon Web Services+8 | 28 patents Immunotherapy targeting CTHRC1 via antibodies, fusion proteins, and T‑cell engagers | — |
| 17 | PharmaTher Provider of AI-based platform for repurposing psychedelic drugs | $8M | 56 mo ago | Public | — | Fabio Chianelli CEO | WeeblyMySQLPHP+17 | — | — |
| 18 | My Intelligent Machines Provider of AI powered platform for life science researcher | $7M | 62 mo ago | Seed | 33 | — | — | — | — |
| 19 | Rapid Novor Provider of antibody sequencing & discovery services | $5M | 70 mo ago | Series A | 70 | — | WordPressMySQLPHP+17 | 23 patents Antibody sequencing, chain pairing, and immunoglobulin light‑chain dimer detection/quantification | 1 launch |
| 20 | Chemical.AI AI-driven tools for chemical synthesis and retrosynthesis | $5M | 43 mo ago | Series B | 150 | Xia Ning Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+16 | 20 patents Carbon nanotube production methods and apparatus for scalable nanomaterial synthesis | 1 job opening · 1 launch |
| 21 | ProteinQure Provider of computational protein drug design platform 53Talent top 28%AI top 30%Innovation top 36%Product top 36% All 10 signals ▾Talenttop 28% AItop 30% Innovationtop 36% Producttop 36% Moattop 37% Patentstop 38% Fundingtop 46% Techbottom 45% Globalbottom 40% Marketbottom 29% Talent: Analyst team rating 4/5 · 4 named leaders on record AI: Classified as an AI company · Product described with: artificial intelligence rank vs industry peers · Fliar Intelligence Index 53/100 | $4M | 12 mo ago | Series A | 18 | Tomas Babej Cofounder and Chief Technology Officer | WordPressProton MailApple iCloud Mail+13 | 9 patents Protein therapeutics targeting the sortilin receptor and natriuretic peptide delivery systems | 2 job openings |
| 22 | ViewsML AI-powered platform for drug development and companion diagnostics 21AI top 45%Funding top 46%Talent bottom 49%Global bottom 36% All 5 signals ▾AItop 45% Fundingtop 46% Talentbottom 49% Globalbottom 36% Marketbottom 21% AI: Product described with: ai-powered Funding: Raised $3.6M across 1 rounds · 1 rounds over 2 yrs (0.5/yr) rank vs industry peers · Fliar Intelligence Index 21/100 | $4M | 2 mo ago | Seed | 8 | Kenneth To CEO | — | — | 1 award |
| 23 | Variational AI based platform for small-molecule drug discovery | $4M | 15 mo ago | Seed | 10 | Handol Kim Co-Founder & CEO | — | 2 patents Design and synthesis of protease inhibitor therapeutics for disease treatment | 2 awards |
| 24 | Optel Group Provider of Track and Trace solutions for the pharma, medical device and healthcare industries | $3M | 40 mo ago | Funding Raised | 124 | — | WordPressUnbounceMySQL+31 | — | — |
| 25 | QuanMol Tech Provider of AI based solutions in molecular designing | $3M | 40 mo ago | Seed | — | Xingyu Shen Co-Founder | — | — | — |
| 26 | Skura Corporation Mobile Sales Enablement platform | $3M | 152 mo ago | Acqui-Hired | 35 | — | — | 2 patents Predictive analytics for audience response in presentation software | — |
| 27 | Remedium AI Provider of an AI-based platform for drug discovery | $3M | — | Seed | — | Robert Murgita Founder | — | — | — |
| 28 | Montrium Cloud-based regulatory document quality & content management platform for life sciences industries | $2M | 58 mo ago | Funding Raised | 64 | — | HubSpot CMS HubFacebook LoginLinkedin Sign-in+26 | — | — |
| 29 | Simmunome Provider of an AI-powered computational models for clinical trial study | $2M | 33 mo ago | Seed | 5 | Armstrong Murira Co-Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+12 | — | — |
| 30 | Andira Digital pharmacotherapeutic platform for providers 21Funding top 50%Talent bottom 49%Market bottom 37%Global bottom 29% All 4 signals ▾Fundingtop 50% Talentbottom 49% Marketbottom 37% Globalbottom 29% Funding: Raised $1.4M across 5 rounds · 5 rounds over 4 yrs (1.2/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 21/100 | $1M | 3 mo ago | Seed | — | Dana Lambert Chief Executive Officer | — | — | — |
| 31 | Ranomics Database of rare genetic variants | $1M | 117 mo ago | Seed | 6 | — | WixSentryBootstrap+17 | 7 patents High-throughput multisite saturation mutagenesis and splice‑junction variant analysis for gene engineering | — |
| 32 | Clemex Technologies Digital microscopic image analysis software | $1M | 168 mo ago | Public | 37 | Yves Bassat CEO | WordPressPleskMySQL+21 | 10 patents Automated microscope slide handling, immersion oil dispensing, and instrument calibration systems. | 3 job openings · 2 launchs |
| 33 | SOLABS Enterprise Quality Management System for Life Sciences Industry | $1M | 207 mo ago | Series A | 28 | — | Windows ServerMicrosoft ASP.NETIIS+2 | — | 3 partnerships |
| 34 | Clincove AI-powered clinical trial management platform designed to streamline and accelerate Phase I–III studies 40AI top 45%Talent top 45%Funding bottom 41%Global bottom 33% All 4 signals ▾AItop 45% Talenttop 45% Fundingbottom 41% Globalbottom 33% AI: Product described with: ai-powered Talent: 2 named leaders on record rank vs industry peers · Fliar Intelligence Index 40/100 | $500K | 8 mo ago | Seed | — | Michael Sousa Chief Technology Officer | — | — | 2 launchs |
| 35 | StokedBio Developer of therapeutics based on AI technology 45Talent top 28%AI top 45%Funding top 46%Market bottom 37% All 5 signals ▾Talenttop 28% AItop 45% Fundingtop 46% Marketbottom 37% Globalbottom 29% Talent: 3 named leaders on record · 3 C-suite/founder profiles curated AI: Product described with: ai-based rank vs industry peers · Fliar Intelligence Index 45/100 | $366K | 1 mo ago | Seed | — | Chris Sinclair Co-Founder | — | — | — |
| 36 | Allumiqs Provider of sample preparation tools and software for omics analytics | $290K | 82 mo ago | Seed | 12 | Peter Hickey Co-Founder | WordPress Block EditorCart FunctionalityWooCommerce+31 | — | 1 partnership |
| 37 | Advanced Chemistry Development Labs Cheminformatics system | $245K | 61 mo ago | Acquired | 183 | — | Cart FunctionalityWooCommerceWordPress+34 | — | 1 launch |
| 38 | viewsIQ Microscopy imaging solutions for academic and clinical applications in the healthcare sector | $238K | 135 mo ago | Seed | 6 | — | — | 13 patents High-resolution digital microscopy imaging with large field-of-view embedded image processing | — |
| 39 | Object Research Systems 3D visualization and analysis solutions | $200K | 192 mo ago | Funding Raised | 20 | — | — | — | — |
| 40 | A.I. VALI Inc AI-based clinical image analysis and reporting tool | $189K | 33 mo ago | Seed | 9 | Azar Azad Founder | — | 5 patents Real-time processing of medical and endoscopic imaging data | 2 awards |
| 41 | Scispot Provider of a lab automation & data platform for life science and biotech laboratories | $125K | 57 mo ago | Seed | 19 | Guru Singh Founder & CEO | WebflowAmazon Web Servicescore-js+15 | — | 2 launchs |
| 42 | CurveNote Cloud-based data sharing and collaborative tool for researchers and scientists | $125K | 60 mo ago | Seed | 4 | Rowan Cockett Co-Founder & CEO | SanityHeadless UIReact+9 | — | 4 launchs |
| 43 | Streamline Genomics Genetic sequence data analysis solution | $120K | 96 mo ago | Seed | 2 | Josette-Renee Landry Founder and president | — | — | — |
| 44 | MetricWire Online platform for researchers to collect data via the smartphone. | $120K | 138 mo ago | Seed | 6 | Brian Stewart Founder & CEO | — | — | — |
| 45 | Cognilab Online research platform for the scientific study of the human brain | $117K | 123 mo ago | Deadpooled | — | Jose Barrios Co-Founder & CEO | — | — | — |
Top 12 Life Sciences Tech companies in Canada
#1
Seed · Vancouver, British Columbia · founded 2022 · 8 employees$3.6Mraised▾
AI-powered platform for drug development and companion diagnostics. The company's key platform technology, Aion, virtualizes the IHC process to forecast biomarker expression spatially and increase efficiencies in drug discovery, as well as hasten patient selection in clinical trials.
- Apr 2026Seed$3.6M
- 2024Seed—
- 2024Seed—
#2
Seed · Vancouver, British Columbia · founded 2020$1.4Mraised▾
Digital pharmacotherapeutic platform for providers. It is a platform for the discovery and creation of natural chemicals with the potential for medicinal usage.
- Feb 2026Seed$152.4K
- Aug 2024Seed$809.9K
- Jun 2024Seed$18.3K
- Oct 2023Seed$212K
#3
Series B · Montreal, Quebec · founded 2017 · 43 employees$63Mraised▾
Provider of next-generation proteomics platform for drug discovery and protein analysis. The company has developed the nELISA, a next-generation ELISA platform by using DNA nanotechnology for measuring proteins and applicable for a wide variety of use cases within drug and biomarker development workflows.
- Sep 2024Series B$42M
- Dec 2021Series A$17M
- 2020Seed—
#4
Seed · Toronto, Ontario · founded 2023$11Mraised▾
Developer of drug formulation science to accelerate the development of therapeutics. The proprietary technology platform, VALIANT, enables the design and optimization of fully optimized formulations of drugs by improving the properties and performance of therapeutic molecules.
- May 2025Seed$7M
- 2023Seed$4M
#5
Seed · Hamilton, Ontario · founded 2024$365.5Kraised▾
Developer of therapeutics based on AI technology. It offers AI-based platform for molecular property prediction and molecular design for drug discovery for antibacterial, antifungal, antiviral, and cancer applications.
- May 2026Seed$365.5K
#6
Series B · Toronto, Ontario · founded 2014 · 18 employees$39.5Mraised▾
Provider of an AI and SaaS-based educational platform for the life science industry. The company has developed a digital platform with learning tools like SALESFitness which is a product that provides trading in clinical sales, MARKETINGFitness a centralized tool for life science marketing of new launches, MSLFitness provides engaging learning experiences and more. There are features for remote video coaching, user engagement tools, and AI-assisted tools for performance tracking.
- Sep 2024Series B$10M
- Jul 2022Series B$18M
- Aug 2020Series A$11.5M
#7
Series A · Toronto, Ontario · founded 2017 · 18 employees$4Mraised▾
Provider of computational protein drug design platform. It predicts the protein folds using hybrid quantum algorithms and performs molecular simulations on GPU superclusters. It designs peptide-based therapeutics using quantum computing, artificial intelligence, and molecular dynamics simulations. Additionally, it uses AlphaGo to train a model and impart reinforced learning which facilitates protein drug designing. It claims to have multiple features including more binding sites, fewer side effects, and easy synthesizing and lab testing.
- May 2025Series A$11M
- Feb 2024Seed—
- Jul 2019Seed$4M
#8
Series D · Toronto, Ontario · founded 2015 · 426 employees$170Mraised▾
Developer of an AI platform for understanding disease biology. The platform integrates scientific data, including publications, multi-omics, and clinical trials, to provide a unified view of diseases. It combines a Biological Evidence Knowledge Graph with foundation models. The platform offers solutions like AI copilots and co-scientists that accelerate discovery. It ingests internal data to create a customized map of disease biology.
- May 2023Series D$70M
- Jan 2022Series C$50M
- Feb 2020Series B$22M
- Jun 2019Series A$5.1M
#9
Seed · Vancouver, British Columbia · founded 2019 · 10 employees$3.5Mraised▾
AI based platform for small-molecule drug discovery. The company's flagship platform, Enki, represents the first commercially available foundation model designed to generate novel, synthesis-ready drug candidates with optimized properties like potency, selectivity, and ADMET profiles
- Feb 2025Seed$5.5M
- Dec 2021Seed$3.5M
#10
Acquired · Montreal, Quebec · founded 2023$11.3Mraised▾
Provider of an AI platform for biopharmaceutical research and development. It offers a flagship product, Reliant Tabular that streamline the process of finding scientific evidence for decision-making, reducing data processing time. It combines an AI engine with customized tools to assist with portfolio strategy and launch success prediction. The platform automates data ingestion and extraction, and provides knowledge graphs to map relationships between trials and mechanisms.
- Aug 2024Seed$11.3M
#11
Series A · Saint laurent, Quebec · founded 2017 · 8 employees$8.1Mraised▾
Developer of targeted therapies modulating membrane receptors for autoimmune diseases. It designs therapies through precision-targeting of key receptors. The company's development programs focus on treating inflammatory autoimmune conditions. It utilizes innovative chemistry to design modulators. The company has a multidisciplinary team focused on drug development. It has a clinical advisory board and a scientific advisory board.
- Sep 2024Series A$8.1M
- Jun 2020Seed—
#12
Seed · Montreal, Quebec · founded 2023$30Mraised▾
Developer of modulating biotherapeutics to address cancer and autoimmune diseases. It has AbiLeap discovery engine that combines continuously learning AI with an extensive database of antigen-antibody interactions to generate fully human, IgG-based multispecific antibodies across cancer and autoimmune applications. The pipeline includes Leap 1121 for auti-immune disease, Leap 1009 and 1030 for solid tumors.
- Jun 2024Seed$18M
- Dec 2023Seed$12M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences Tech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Biotechnology is moving in Canada
A read on the academic research around Biotechnology — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 990 Canada-affiliated papers.
- Ministry of Agriculture118
- Ministry of Education70
- University of Toronto61
- McGill University60
- Agriculture and Agri-Food Canada58
- Gene3→32
- Mutant2→13
- Genome2→12
- Transcription factor2→11
- Transcription (linguistics)1→9
- Gene2→40
- Fermentation1→12
- Antimicrobial1→9
- Population1→9
- Agriculture1→8
- Agriculture3→10
- Antibiotic resistance3→10
- Antimicrobial1→6
- Human health2→7
- Microbiome2→6
Where biotechnology is researched across Canada
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Who's filing biotechnology patents in Canada
Canada biotechnology patent filing is accelerating — 18,553 filings from 8,000 assignees (2016–2025), led by UNIV British Columbia, UNIV Health Network, NAT RES Council Canada; annual filings 1716→1734.
- UNIV British Columbia1570
- UNIV Health Network1208
- NAT RES Council Canada900
- UNIV Alberta753
- CA NAT Research Council699
- Medicago680
- UNIV Saskatchewan597
- Zymeworks594
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.